International Society of Liquid Biopsy shared a post on X about a recent paper by Nazila Bahmaie
“ ISLB Research Highlight!
Circulating Tumor Cells (CTCs): Revolutionizing Cancer Management
Key Insights:
- CTCs enable phenotypic cell plasticity and tumor heterogeneity analysis.
- Serve as biomarkers for relapse, drug resistance, and therapy response.
- Potential use in personalized drug development and cell-based vaccines .
CTCs are paving the way for personalized and translational cancer medicine.
Discover More.”
“A revolutionary era in advancing precision immuno-oncology; role of circulating tumor cells”
Authors: Nazila Bahmaie, Ozen Ozensoy Guler,
More posts featuring International Society of Liquid Biopsy.
